OneMedNet director buys 158,730 shares

OneMedNet Corp director and 10% owner Thomas Kosasa bought 158,730 shares of common stock at $0.63 per share.

Rhea-AI Filing Summary

OneMedNet Corp director and 10% owner Thomas Kosasa bought 158,730 shares of common stock at $0.63 per share. The $100,000 investment was made on June 12, 2026 through a subscription agreement, with the share price based on the 10-day volume-weighted average price. Following this purchase, Kosasa directly holds 17,088,874 shares of OneMedNet.

Insights

Equity markets analyst

Director and 10% owner increases stake with a $100,000 share purchase.

Director and 10% owner Thomas Kosasa entered a subscription agreement to invest $100,000 in OneMedNet Corp, receiving 158,730 common shares at $0.63 per share. The price reflects the 10-day volume-weighted average price before the transaction date.

After this purchase, Kosasa directly owns 17,088,874 shares. The filing shows a single open-market type purchase, with no concurrent sales or derivative exercises, indicating a net increase in his equity exposure based on the disclosed data.

Insider Trade Summary

Net Buyer: 158,730 shares

Net Buy 1 txn

Insider Kosasa Thomas

Role Director, 10% Owner

Bought 158,730 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	158,730	$0.63	$100K

Holdings After Transaction: Common Stock — 17,088,874 shares (Direct)

Footnotes (2)

1. F1. On June 12, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.
2. F2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

Key Figures

Shares purchased: 158,730 shares Purchase price: $0.63 per share Investment amount: $100,000 +2 more

5 metrics

Shares purchased 158,730 shares Common stock bought by Thomas Kosasa on June 12, 2026

Purchase price $0.63 per share Volume-weighted average price for 10 trading days before purchase

Investment amount $100,000 Subscription agreement investment in OneMedNet by Kosasa

Shares held after transaction 17,088,874 shares Kosasa direct OneMedNet holdings following the purchase

Transactions classified as buys 1 transaction Form 4 transaction summary net-buy activity

Key Terms

subscription agreement, volume-weighted average price (VWAP), open-market purchase, 10% owner

4 terms

subscription agreement financial

"the issuer entered into a subscription agreement with the reporting person for a $100,000 investment"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

volume-weighted average price (VWAP) financial

"The shares were valued at the volume-weighted average price (VWAP) of the issuer"

Volume-weighted average price (VWAP) is the average price of a security over a trading period where each trade’s price is weighted by how many shares were traded, so larger trades pull the average more than tiny ones. Investors and traders use VWAP as a benchmark to judge whether a trade was executed at a favorable price—similar to checking whether you paid more or less than the typical price when most people were buying or selling.

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

10% owner financial

"is_ten_percent_owner": 1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OneMedNet (ONMD) director Thomas Kosasa do in this Form 4?

Thomas Kosasa, a director and 10% owner of OneMedNet, purchased 158,730 shares of common stock. The shares were acquired via a $100,000 subscription agreement at $0.63 per share, increasing his direct holdings to 17,088,874 shares.

How many OneMedNet (ONMD) shares did Thomas Kosasa buy and at what price?

Kosasa bought 158,730 OneMedNet common shares at $0.63 per share. The price was set using the 10-day volume-weighted average price, resulting in a total investment of approximately $100,000 under a subscription agreement.

What is Thomas Kosasa’s OneMedNet (ONMD) stake after this transaction?

After the reported transaction, Kosasa directly holds 17,088,874 OneMedNet common shares. This reflects the addition of 158,730 shares purchased for $100,000 under a subscription agreement dated June 12, 2026, with pricing based on the 10-day VWAP.

How was the purchase price determined in the OneMedNet (ONMD) Form 4 transaction?

The purchase price of $0.63 per OneMedNet share was based on the 10-day volume-weighted average price immediately before the purchase date. This VWAP-based pricing was specified in the subscription agreement tied to the $100,000 investment.

Was the OneMedNet (ONMD) Form 4 transaction an open-market purchase?

The transaction is coded as an open-market purchase, but executed through a subscription agreement. Kosasa invested $100,000 for 158,730 shares at $0.63, with the price set using the prior 10-day volume-weighted average trading price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 06:09 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kosasa Thomas

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD, SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		P(1)		158,730	A	$0.63(2)	17,088,874	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 12, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

	/s/ Robert Golden, Attorney-in-Fact	06/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)